Recent advances in the development of peptide nucleic acid as a gene-targeted drug

Bibliography

• NIELSEN PE, EGHOLM M, BERG RH, BUCHARDT O: Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide. Science (1991) 254:1498–1500.
   Google Scholar
• •This is the original paper on PNA.
   Google Scholar
• NIELSEN PE: PNA Technology. In: Peptide nucleic acids. Methods and protocols. Nielsen PE (Ed.), Humana Press, Totowa, NJ, USA (2002):3–26.
   Google Scholar
• NIELSEN PE: Peptide nucleic acids: on the road to new gene therapeutic drugs. Pharmacol Toxicol (2000) 86:3–7.
   PubMedGoogle Scholar
• RAY A, NORDEN B: Peptide nucleic acid (PNA): Its medical and biotechnical applications and promise for the future. FASEB (2000) 14:1041–1060.
   PubMed Web of Science ®Google Scholar
• ELAYADI AN, COREY DR: Application of PNA and LNA oligomers to chemotherapy. Curc Opin. Investig. Drugs (2001) 2:558–561.
   PubMedGoogle Scholar
• EGHOLM M, BUCHARDT O, CHRISTENSEN L et al.: PNA hybridizes to complementary oligonucleotides obeying the Watson-Crick hydrogen-bonding rules. Nature (1993) 365:566–568.
   PubMed Web of Science ®Google Scholar
• •This paper describes the hybridisation properties of PNA to single-stranded, mixed sequence targets.
   Google Scholar
• TOMAC S, SARKAR M, RATILAINEN T et al.: Ionic effects on the stability and conformation of peptide nucleic acid complexes. Jim. Chem. Soc. (1996) 118:5544–5552.
   Web of Science ®Google Scholar
• RATILAINEN T, HOLMEN A, TUITE E et al.: Hybridization of peptide nucleic acid. Biochemistry (1998) 37:12331–12342.
   PubMed Web of Science ®Google Scholar
• RATILAINEN T, HOLMEN A, TUITE E, NIELSEN PE, NORDEN B: Thermodynamics of sequence-specific binding of PNA to DNA. Biochemistry (2000) 39:7781–7791.
   PubMed Web of Science ®Google Scholar
• MAHER LJ III, WOLD B, DERVAN PB: Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science (1989) 245:725–730.
   PubMed Web of Science ®Google Scholar
• MOSER H, DERVAN PB: Sequence-specific cleavage of double helical DNA by triple helix formation. Science (1987) 238:645–650.
   PubMed Web of Science ®Google Scholar
• LE DOAN T, PERROUAULT L, PRASEUTH D et al.: Sequence-specific recognition, photocrosslinking and cleavage of the DNA double helix by an oligo-[c]-thymidilate covalently linked to an azidoproflavine derivative. Nucleic Adds Res. (1987) 15:7749–7760.
   PubMed Web of Science ®Google Scholar
• BEERLI RR, DREIER B, BARBAS CF: Positive and negative regulation of endogenous genes by designed transcription factors. Proc. Nati Acad. ScL USA (2000) 97:1495–1500.
   PubMed Web of Science ®Google Scholar
• DERVAN PB, BURLI RW: Sequence-specific DNA recognition by polyamides. Curc Opin. Chem. Biol. (1999) 3:688–693.
   PubMed Web of Science ®Google Scholar
• NIELSEN PE, EGHOLM M, BUCHARDT O: Evidence for (PNA) 2' DNA triplex structure upon binding of PNA to dsDNA by strand displacement. I. MM. Recognit. (1994) 7:165–170.
   PubMedGoogle Scholar
• CHERNY DY, BELOTSERKOVSKII BP, FRANK-KAMENETSKII MD et al.: DNA unwinding upon strand-displacement binding of a thymine-substituted polyamide to double-stranded DNA. Proc. Natl. Acad. ScL USA (1993) 90:1667–1670.
   PubMed Web of Science ®Google Scholar
• PEFFER NJ, HANVEY JC, BISI JE et al.:Strand-invasion of duplex DNA by peptide nucleic acid oligomers. Proc. Natl Acad. ScL USA (1993) 90:10648–10652.
   PubMed Web of Science ®Google Scholar
• NIELSEN PE: Peptide nucleic acid: a versatile tool in genetic diagnostics and molecular biology. Curr. Opin. Biotechnol (2001) 12:16–20.
   PubMed Web of Science ®Google Scholar
• BENTIN T, NIELSEN PE: Enhanced peptide nucleic acid binding to supercoiled DNA: possible implications for DNA 'breathing' dynamics. Biochemistry (1996) 35:8863–8869.
   PubMed Web of Science ®Google Scholar
• ••This paper illustrates improved strand invasion for supercoiled DNA targets.
   Google Scholar
• DATTA B, SCHMITT C, ARMITAGE BA: Formation of a PNA2-DNA2 hybrid quadruplex. I Am. Chem. Soc. (2003) 125:4111–4118.
   PubMed Web of Science ®Google Scholar
• ARTHANARI H, BOLTON PH: Functional and dysfunctional roles of quadruplex DNA in cells. Chem. Biol. (2001) 8:221–230.
   PubMed Web of Science ®Google Scholar
• CECH TR: Life at the end of the chromosome: telomeres and telomerase. Angew. Chem. hat. Ed (2000) 39:35–43.
   Google Scholar
• SIDDIQUI-JAIN A, GRAND CL, BEARSS DJ, HURLEY LH: Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYCtranscription. Proc. Nati Acad. Sci. USA (2002) 99:11593–11598.
   PubMed Web of Science ®Google Scholar
• DARNELL JC, JENSEN KB, JIN P, BROWN V, WARREN ST, DARNELL RB: Fragile X mental retardation protein targets G quartet mRNAs important for neuronal function. Cell (2001) 107:489–499.
   PubMed Web of Science ®Google Scholar
• DEMIDOV VV, POTAMAN VN, FRANK-KAMANETSKII MD et al.: Stability of peptide nucleic acids in human serum and cellular extracts. Biochem. Pharmacol (1994) 48:1310–1313.
   PubMed Web of Science ®Google Scholar
• •This paper establishes the biochemical stability of PNA.
   Google Scholar
• MCMAHON BM, MAYS D, LIPSKY J, STEWART JA, FAUQ A, RICHELSON E: Pharmacokinetics and tissue distribution of a peptide nucleic acid after intravenous administration. Antisense Nucleic Acid Drug Devel (2002) 12:65–70.
   PubMedGoogle Scholar
• •This paper studies the fate of PNA after injection into rats.
   Google Scholar
• STEIN CA: Two problems in antisense biotechnology: in vitro delivery and the design of antisense experiments. Biochim. Biophys. Acta (1999) 1489:45–52.
   PubMed Web of Science ®Google Scholar
• KOPPELHUS U, NIELSEN PE: Cellular delivery of peptide nucleic acid (PNA). Adv. Drug Deliv. Rev (2003) 55:267–280.
   PubMed Web of Science ®Google Scholar
• WITTUNG P, KAJANUS J, EDWARDS K, NIELSEN P, NORDEN B, MALMSTROEM BG: Phospholipid membrane permeability of peptide nucleic acid. FEBS Lett. (1995) 375:27–29.
   PubMedGoogle Scholar
• TYLER BM, MCCORMICK DJ, HOSHALL CV et al.: Specific gene blockade shows that peptide nucleic acids readily enter neuronal cells in vivo. FEBS Lett. (1998) 421:280–284.
   PubMed Web of Science ®Google Scholar
• TYLER BM, JANSEN K, MCCORMICK DJ et al.: Peptide nucleic acids targeted to the neurotensin receptor and administered i.p. cross the blood-brain barrier and specifically reduce gene expression. Proc. Natl. Acad. Sci. USA (1999) 96:7053–7058.
   PubMed Web of Science ®Google Scholar
• ••This paper demonstrates antisense effectsof an unmodified PNA that crosses the BBB and enters neuronal cells.
   Google Scholar
• FRASER GL, HOLMGREN J, CLARKE PBS, WAHLESTEDT C: Antisense inhibition of delta-opioid receptor gene function in vivo by peptide nucleic acids. Pharmacol (2000) 57:725–731.
   Web of Science ®Google Scholar
• REZAEI K, XU IS, WU WP et al.: Intrathecal administration of PNA targeting galanin receptor reduces galanin mediated inhibitory effect in the rat spinal cord. Neuromport (2001) 12:317–320.
   PubMed Web of Science ®Google Scholar
• MCMAHON BM, STEWART JA, BITNER MD, FAUQ A, MCCORMICK DJ, RICHELSON E: Peptide nucleic acids specifically cause antigene effects in vivo by systemic injection. Life Sci. (2002) 71:325–337.
   PubMed Web of Science ®Google Scholar
• MCMAHON BM, STEWART J, FAUQ A, YOUNKIN S, YOUNKIN L, RICHELSON E: Peptide nucleic acids targeted to the amyloid precursor protein. Neurosci. (2003) 20:261–265.
   Web of Science ®Google Scholar
• ZELPHATI O, SZOKA FC: Mechanism of oligonucleotide release from cationic liposomes. Proc. Natl. Acad. Sci. USA (1996) 93:11493–11498.
   PubMed Web of Science ®Google Scholar
• HAMILTON SE, SIMMONS CG, KATHIRIYA IS, COREY DR: Cellular delivery of peptide nucleic acids and inhibition of human telomerase. Chem. Biol. (1999) 6:343–351.
   PubMed Web of Science ®Google Scholar
• •This paper describes transfection of PNA using a carrier DNA.
   Google Scholar
• SIMMONS CG, PITTS AE, MAYFIELD LD, SHAY JW, COREY DR: Synthesis and membrane permeability of PNA-peptide conjugates. Bioorg. Med. Chem. Lett. (1997) 7:3001–3006.
   Web of Science ®Google Scholar
• POOGA M, SOOMETS U, HALLBRINK M et al.: Cell penetrating PNA constructs regulate galanin receptor levels and modify pain transmission in vivo. Nat. Biotechnol (1998) 16:857–861.
   PubMed Web of Science ®Google Scholar
• CUTRONA G, CARPANETO EM, ULIVI M et al.: Effects in live cells of a c-myc anti-gene PNA linked to a nuclear localization signal. Nat. Biotechnol. (2000) 18:300–303.
   PubMed Web of Science ®Google Scholar
• ••Effective cell uptake, nuclear localisationand antigene activity of a peptide-PNA conjugate are described.
   Google Scholar
• CUTRONA G, CARPANETO EM, PONZANELLI A: Inhibition of the translocated c-mycin Burkitt's lymphoma by a PNA complementary to the Ett enhancer. Cancer Res. (2003) 63:6144–6148.
   PubMed Web of Science ®Google Scholar
• BASU S, WICKSTROM E: Synthesis and characterization of a peptide nucleic acid conjugated to a D-peptide analog of insulin-like growth factor 1 for increased cellular uptake. Bioconj. Chem. (1997) 8:481–488.
   PubMed Web of Science ®Google Scholar
• ALDRIAN-HERRADA G, DESARMENIEN MG, ORCEL H et al.: A peptide nucleic acid (PNA) is more rapidly internalized in cultured neurons when coupled to a retro-inverso delivery peptide. The antisense activity depresses the target mRNA and protein in magnocellular oxytocin neurons. Nucleic Adds Res. (1998) 26:4910–4916.
   Google Scholar
• GOOD L, AWASTHI SK, DRYSELIUS R, LARSSON O, NIELSEN PE: Bactericidal antisense effects of peptide-PNA conjugates. Nat. Biotechnol (2001) 19:360–364.
   PubMed Web of Science ®Google Scholar
• ••This paper describes antibiotic propertiesof PNA directed towards E. coil.
   Google Scholar
• KOPPELHUS U, AWASTHI SK, ZACHAR V, HOLST HU, EBBESEN P, NIELSEN PE: Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Add Drug Devel (2002) 12:51–63.
   PubMedGoogle Scholar
• VOCERO-AKBANI AM, HEYDEN NV, LISSY NA, RATNER L, DOWDY SF: Killing HIV-infected cells by transduction with an HIV protease-activated caspase-3 protein. Nat. Med. (1999) 5:29–33.
   PubMed Web of Science ®Google Scholar
• LEWIN M, CARLESSO N, TUNG C et al.: Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells. Nat. Biotechnol (2000) 18:410–414.
   PubMed Web of Science ®Google Scholar
• WENDER PA, MITCHELL DJ, PATTABIRAMAN K, PELKEY ET, STEINMAN L, ROTHBARD JB: The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc. Nati Acad. Sci. USA (2000) 97:13003–13008.
   PubMed Web of Science ®Google Scholar
• ZHOU P, WANG M, DU L, FISHER GW, WAGGONER A, LY DH: Novel binding and efficient cellular uptake of guanidine-based peptide nucleic acids (GPNA)..I. Am. Chem. Soc. (2003) 125:6878–6879.
   PubMed Web of Science ®Google Scholar
• ••This paper describes cell uptakeand DNA binding properties of a cationic PNA analogue.
   Google Scholar
• HAAIMA G, LOHSE A, BUCHARDT O, NIELSEN PE: Peptide nucleic acids (PNAs) containing thymine monomers derived from chiral amino acids: hybridization and solubility properties of D-lysine PNA. Angew. Chem. Int. Ed. (1996) 35:1939–1942.
   Web of Science ®Google Scholar
• •This paper reports on backbone-modified PNAs.
   Google Scholar
• POSCHL A, SFORZA S, HAAIMA G, DAHL O, NIELSEN PE: Peptide nucleic acids (PNAs) with a functional backbone. Tetrahedron Lett. (1998) 39:4707–4710.
   Web of Science ®Google Scholar
• SFORZA S, CORRADINI R, GHIRARDI S, DOSSENA A, MARCHELLI R: DNA binding of a D-lysine-based chiral PNA: direction control and mismatch recognition. Eur. Org. Chem. (2000):2905–2913.
   Google Scholar
• PARDRIDGE WM, BOADA RJ, KANG Y: Vector-mediated delivery of a polyamide ('peptide') nucleic acid analogue through the blood-brain barrier in vivo. Proc. Nati Acad. Sci. USA (1995) 92:5592–5596.
   PubMed Web of Science ®Google Scholar
• •This was also the first paper that demonstrated PNA antisense in live animals.
   Google Scholar
• ZHANG X, SIMMONS C, COREY DR: Liver cell specific targeting of peptide nucleic acid oligomers. Bioorg. Med. Chem. Lett. (2001) 11:1269–1272.
   PubMed Web of Science ®Google Scholar
• HAMZAVI R, DOLLE F, TAVITIAN B, DAHL O, NIELSEN PE: Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers. Bioconj. Chem. (2003) 14:941–954.
   PubMed Web of Science ®Google Scholar
• •This paper reports backbone-modified PNAs with improved tissue targeting.
   Google Scholar
• LANGER K, COESTER C, WEBER C, VON BRIESEN H, KREUTER J: Preparation of avidin-labeled protein nanoparticles as carriers for biotinylated peptide nucleic acid. Eur. I Pharmaceur Biopharmaceur (2000) 49:303–307.
   PubMed Web of Science ®Google Scholar
• COESTER C, KREUTER J, VON BRIESEN H, LANGER K: Preparation of avidin-labeled gelatin nanoparticles as carriers for biotinylated peptide nucleic acid (PNA). Int. .1. Pharm. (2000) 196:147–149.
   PubMed Web of Science ®Google Scholar
• MURATOVSKA A, LIGHTOWLERS RN, TAYLOR RW et al.: Targeting peptide nucleic acid (PNA) oligomers to mitochondria within cells by conjugation to lipophilic cations: implications for mitochondrial DNA replication, expression and disease. Nucleic Acids Res. (2001) 29:1852–1863.
   PubMed Web of Science ®Google Scholar
• LJUNGSTROM T, KNUDSEN H, NIELSEN PE: Cellular uptake of adamantyl conjugated peptide nucleic acids. Bioconj. Chem. (1999) 10:965–972.
   PubMed Web of Science ®Google Scholar
• SCARFI S, GASPARINI A, DAMONTE G, BENATTI U: Synthesis, uptake, and intracellular metabolism of a hydrophobic tetrapeptide-peptide nucleic acid (PNA)-biotin molecule. Biochem. Biophys. Res. Commun. (1997) 236:323–326.
   PubMed Web of Science ®Google Scholar
• BOFFA LC, SCARFI S, MARIANI MR et al.: Dihydrotestosterone as a selective cellular/nuclear localization vector for anti-gene peptide nucleic acid in prostatic carcinoma cells. Cancer Res. (2000) 60:2258–2262.
   PubMed Web of Science ®Google Scholar
• •Antigene PNAs are targeted to prostate cancer cells using a conjugated steroid group.
   Google Scholar
• REBUFFAT AG, NAWROCKI AR, NIELSEN PE et al.: Gene delivery by a steroid-peptide nucleic acid conjugate. FASEB (2002) 16:1426–1428.
   PubMed Web of Science ®Google Scholar
• KARRAS JG, MAIER MA, LU T, WATT A, MANOHARAN M: Peptide nucleic acids are potent modulators of endogenous pre-mRNA splicing of the murine interleukin-5 receptor-a chain. Biochemistry (2001) 40:7853–7859.
   PubMed Web of Science ®Google Scholar
• ••This paper demonstrates the use of PNAto regulate RNA splicing as a way of controlling gene expression.
   Google Scholar
• CHEAH IK, CHEEMA SS, LANGFORD SJ et al: Design and application of a peptide nucleic acid sequence targeting the p75 neurotrophin receptor. Bioorg. Med. Chem. Lett. (2003) 13:2377–2380.
   PubMed Web of Science ®Google Scholar
• ADLERZ L, SOOMETS U, HOLMLUND L, VIIRLAID S, LANGEL U, IVERFELDT K: Down- regulation of amyloid precursor protein by peptide nucleic acid oligomer in cultured rat primary neurons and astrocytes. Neurosci Lett. (2003) 336:55–59.
   PubMed Web of Science ®Google Scholar
• MCMAHON BM, STEWART J, FAUQ A, YOUNKIN S, YOUNKIN L, RICHELSON E: Using peptide nucleic acids as gene-expression modifiers to reduce beta-amyloid levels.' MM. Neurosci. (2002) 19:71–76.
   PubMed Web of Science ®Google Scholar
• LUGER K, MADER AW, RICHMOND RK, SARGENT DF, RICHMOND TJ: Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature (1997) 389:251–260.
   PubMed Web of Science ®Google Scholar
• GOTTESFELD JM, MELANDER C, SUTO RK, RAVIOL H, LUGER K, DERVAN PB: Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides.J. MM. Biol. (2001) 309:615–629.
   PubMed Web of Science ®Google Scholar
• BOFFA LC, CARPANETO EM, ALLFREY VG: Isolation of active genes containing CAG repeats by DNA strand invasion by a peptide nucleic acid. Proc. NatL Acad. Sci. USA (1995) 92:1901–1905.
   PubMed Web of Science ®Google Scholar
• BOFFA LC, MORRIS PL, CARPANETO EM, LOUISSAINT M, ALLFREY VG: Invasion of the CAG triplet repeats by a complementary peptide nucleic acid inhibits transcription of the androgen receptor and TATA-binding protein genes and correlates with refolding of an active nucleosome containing a unique AR gene sequence. J. Bio/. Chem. (1996) 271:13228–13233.
   PubMed Web of Science ®Google Scholar
• CROOKE ST: Comments on evaluation of antisense drugs in the clinic. Antisense Nucleic Add Drug Dev. (2000) 10:225–227.
   PubMedGoogle Scholar
• GOOD L, NIELSEN PE: Inhibition of translation and bacterial growth by peptide nucleic acid targeted to ribosomal RNA. Proc. NatL Acad. Sci. USA (1998) 95:2073–2076.
   PubMed Web of Science ®Google Scholar
• GOOD L, NIELSEN PE: Antisense inhibition of gene expression in bacteria by PNA targeted to mRNA. Nat. BiotechnoL (1998) 16:355–358.
   PubMed Web of Science ®Google Scholar
• STOCK RP, OLVERA A, SANCHEZ R et al.: Inhibition of gene expression in Entamoeba histolytica with antisense peptide nucleic acid oligomers. Nat. Biotechnol (2001) 19:231–234.
   PubMed Web of Science ®Google Scholar
• MOLLEGAARD NE, BUCHARDT O, EGHOLM M, NIELSEN PE: Peptide nucleic acid. DNA strand displacement loops as artificial transcription promoters. Proc. Natl. Acad. Sci. USA (1994) 91:3892–3895.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that a PNA strand invasion complex can act as an artificial promoter for transcription.
   Google Scholar
• WANG G, XU X, PACE B et al.: Peptide nucleic acid (PNA) binding-mediated induction of human y-globin gene expression. Nucleic Acids Res. (1999) 27:2806–2813.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that PNA strand invasion can activate gene expression in cells.
   Google Scholar
• MAPP AK, ANSARI AZ, PTASHNE M, DERVAN PB: Activation of gene expression by small molecule transcription factors. Proc. Natl. Acad. Sci. USA (2000) 97:3930–3935.
   PubMed Web of Science ®Google Scholar
• STANOJEVIC D, YOUNG RA: A highly potent artificial transcription factor. Biochemistry (2002) 41:7209–7216.
   PubMed Web of Science ®Google Scholar
• LIU B, HAN Y, FERDOUS A, COREY DR, KODADEK T: Transcription activation by a PNA-peptide chimera in a mammalian cell extract. Chem. Bid. (2003) 10:909–916.
   PubMed Web of Science ®Google Scholar
• NORTON JC, PIATYSZEK MA, WRIGHT WE, SHAY JW, COREY DR: Inhibition of human telomerase activity by peptide nucleic acids. Nat. Biotechnol (1996) 14:615–619.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates PNA targeting of an RNA-protein complex and inhibition of enzymatic function.
   Google Scholar
• HAMILTON SE, PITTS AE, KATIPALLY RR et al: Identification of determinants for inhibitor binding within the active site of human telomerase using PNA scanning. Biochemistry (1997) 36:11873–11880.
   PubMed Web of Science ®Google Scholar
• PITTS AE, COREY DR: Inhibition of human telomerase by O-methyl RNA. Proc. Natl. Acad. Sci. USA (1998) 95:11549–11554.
   PubMed Web of Science ®Google Scholar
• HARRISON JG, FRIER C, LAURANT R,DENNIS R, RANEY KD, BALASUBRAMANIAN S: Inhibition of human telomerase by PNA-cationic peptide conjugates. Bioorg. Med. Chem. Let. (1999) 9:1273–1278.
   PubMed Web of Science ®Google Scholar
• VILLA R, FOLINI M, LUALDI S, VERONESE S, DAIDONE MG, ZAFFARONI N: Inhibition of telomerase activity by a cell-penetrating peptide nucleic acid construct in human melanoma cells. FEBS Lett. (2000) 473:241–248.
   PubMed Web of Science ®Google Scholar
• HERBERT BS, PITTS AE, BAKER SI et al.: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc. NatL Acad. Sci. USA (1999) 96:14276–14281.
   PubMed Web of Science ®Google Scholar
• AUTEXIER C: Telomerase as a possible target for anticancer therapy. Chem. Biol. (1999) 6:R299–R303.
   PubMed Web of Science ®Google Scholar
• KARRAS JG, MCKAY RA, DEAN NM, MONIA BP: Deletion of individual exons and induction of soluble murine interleukin-5 receptor-alpha chain expression through antisense oligonucleotide-mediated redirection of pre-mRNA splicing. MM. Pharmacol (2000) 58:380–387.
   PubMed Web of Science ®Google Scholar
• SAZANI P, GEMIGNANI F, KANG S-H et al.: Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat. Biotechnol (2002) 20:1228–1233.
   PubMed Web of Science ®Google Scholar
• ••This paper describes the effect of a splice site-selecting PNA in whole animals.
   Google Scholar
• BORGATTI M, ROMANELLI A, SAVIANO M et al.: Resistance of decoy PNA-DNA chimeras to enzymatic degradation in cellular extracts and serum. Oncol Res. (2003) 13:279–287.
   Google Scholar
• BORGATTI M, LAMPRONTI I, ROMANELLI A et al.: Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Spl binding sites., Biol. Chem. (2003) 278:7500–7509.
   Web of Science ®Google Scholar
• BORGATTI M, BREDA L, CORTESI R et al.: Cationic liposomes as delivery systems for double-stranded PNA-DNA chimeras exhibiting decoy activity against NF-kappaB transcription factors. Biochem. Pharmacol (2002) 64:609–616.
   PubMedGoogle Scholar
• MISCHIATI C, BORGATTI M, FERIOTTO G et al.: Inhibition of HIV-1 LTR-driven M vitro transcription by molecular hybrids based on peptide nucleic acids mimicking the NF-kappaB binding site. Int.' MM. Med. (2002) 9:633–639.
   PubMed Web of Science ®Google Scholar
• HECKL S, PIPKORN R, WALDECK W: Intracellular visualization of prostate cancer using magnetic resonance imaging. Cancer Res. (2003) 63:4766–4772.
   PubMed Web of Science ®Google Scholar
• LEE HJ, BOADO RJ, BRAASCH DA, COREY DR, PARDRIDGE WM: Imaging gene expression in brain in vivo in transgenic mouse model of Huntington's disease with antisense radiopharmaceutical and drug-targeting technology. J. Nucl. Med. (2002) 43:948–956.
   PubMed Web of Science ®Google Scholar
• SHI N, BOADO RJ, PARDRIDGE WM: Antisense imaging of gene expression in the brain M vivo. Proc. Natl. Acad. Sci. USA (2000) 97:14709–14714.
   PubMed Web of Science ®Google Scholar
• TACKETT AJ, COREY DR, RANEY KD: Non-Watson-Crick interactions between PNA and DNA inhibit the ATPase activity of bacteriophage T4 Dda helicase. Nucleic Acids Res. (2002) 30:950–957.
   PubMed Web of Science ®Google Scholar
• DOYLE DF, BRAASCH DA, SIMMONS CG, JANOWSKI BA, COREY DR: Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length. Biochemistry (2001) 40:53–64.
   PubMed Web of Science ®Google Scholar
• •This paper provides a comprehensive study of PNA antisense in cells and shows how inhibition of translation is highly context dependent.
   Google Scholar
• KNUDSEN H, NIELSEN PE: Antisense properties of duplex- and triplex-forming PNAs. Nucleic Adds Res. (1996) 24:494–500.
   PubMed Web of Science ®Google Scholar
• •This paper demonstrates that homopyrimidine PNAs can be effective antisense agents, indicating that triplex formation can improve therapeutic potential.
   Google Scholar
• HAYES JJ, TULLIUS T, WOLFFE AP: The structure of DNA in a nucleosome. Proc. Natl. Acad. Sci. USA (1990) 87:1229–1233.
   Google Scholar
• GOTTESFELD JM, MELANDER C, SUTO RK, RAVIOL H, LUGER K, DERVAN PB: Sequence-specific recognition of DNA in the nucleosome by pyrrole-imidazole polyamides. Md. Biol. (2001) 309:615–629.
   PubMed Web of Science ®Google Scholar
• LOHSE J, DAHL O, NIELSEN PE: Double duplex invasion by peptide nucleic acid: a general principle for sequence-specific targeting of double-stranded DNA. Proc. Nati Acad. ScL USA (1999) 96:11804–11808.
   PubMed Web of Science ®Google Scholar
• ••The double-duplex invasion strategysignificantly extends PNA recognition of double-stranded DNA.
   Google Scholar
• DEMIDOV W, PROTOZANOVA E, IZVOLSKY KI, PRICE C, NIELSEN PE, FRANK-KAMANETSKII MD: Kinetics and mechanism of the DNA double helix invasion by pseudocomplementary peptide nucleic acids. Proc. Nati Acad. Sci. USA (2002) 99:5953–5958.
   PubMed Web of Science ®Google Scholar
• SCHMIDT KS, BOUDVILLAIN M, SCHWARTZ A et al.: Monofunctionally trans-diammine platinum(II)-modified peptide nucleic acid oligomers: a new generation of potential antisense drugs. Chem. Eur. (2002) 8:5566–5570.
   PubMed Web of Science ®Google Scholar
• LAGOS-QUINTANA M, RAUHUT R, LENDECKEL W, TUSCHL T: Identification of novel genes coding for small expressed RNAs. Science (2001) 294:853–858.
   PubMed Web of Science ®Google Scholar
• LAU NC, LIM LP, WEINSTEIN EG, BARTEL DP: An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science (2001) 294:858–862.
   PubMed Web of Science ®Google Scholar
• LEE RC, AMBROS V: An extensive class of small RNAs in Caenorhabditis elegans. Science (2001) 294:862–864.
   PubMed Web of Science ®Google Scholar